An updated Code of Conduct for the application of data-driven technologies in the NHS was published on Tuesday of this week – the code ‘sets out what the NHS expects from companies who are developing new technologies for the health system, and what they can expect in return.
In order to assist applicants and researchers, the HRA have created new pages that set out the approvals process for data-driven technology research.
The section incorporates two pages of support –
- I’m developing medical software – this signposts further information to distinguish whether your software may be a medical device and therefore may need Medicines and Healthcare products Regulatory Agency (MHRA) authorisation
- I’d like to use patient data – this signposts further information in the form of a joint guidance document by the HRA, MHRA and NHS Digital
The help pages will be added to the Clinical Governance section of the blog, for ease of access.
#DataSavesLives – using patient data for research
Research transparency – HRA response to the Science and Technology Committee
CQC inspection to include research in NHS Trusts
Medical research: articles/blogs of interest










REF 2029 Sector Survey: Have Your Say
BU methods paper reached 2,500 reads
UKCGE Recognised Research Supervision Programme: Applications Close 19 October
Dr. Orlanda Harvey interviewed as expert
Dr. Paul Whittington attends Technology and the SEND Reforms Roundtable in the House of Commons
Dr. Paul Whittington joins Bett 2026 DfE Assistive Technology Roundtable
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease